ACTIVATE: A Computerized Training Program for Children With ADHD

Sponsor
New York University (Other)
Overall Status
Completed
CT.gov ID
NCT02562469
Collaborator
(none)
20
1
1
23
0.9

Study Details

Study Description

Brief Summary

A preliminary clinical trial of ACTIVATE will be conducted in a sample of children with ADHD.

ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see:

www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking).

Condition or Disease Intervention/Treatment Phase
  • Other: ACTIVATE
N/A

Detailed Description

In an open clinical trial, ACTIVATE, a computer-based neurocognitive intervention will be evaluated to determine its effectiveness in improving symptoms of attention-deficit/hyperactivity disorder (ADHD) and related impairments. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking). Youth between the ages of 7-11 will be recruited and assessed for ADHD and assigned to the ACTIVATE intervention. Assessment of outcomes will occur before, weekly during treatment, and immediately post-treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
ACTIVATE: A Computerized Training Program for Children With ADHD
Actual Study Start Date :
Sep 1, 2015
Actual Primary Completion Date :
Aug 1, 2017
Actual Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: ACTIVATE

ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking). ACTIVATE Is completed at home via computer with parent support. ACTIVATE intervention is conducted 3-5 times per week for between 20-30 minutes over the course or 3-4 months.

Other: ACTIVATE
A home-based computerized brain training intervention for youth.

Outcome Measures

Primary Outcome Measures

  1. ADHD symptoms on the Disruptive Behavior Rating Scale [Change in ADHD symptoms at postreatment, which is expected to occur betwen 12-18 weeks from start of treatment]

    Change in ADHD symptoms over the course of treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 11 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children ages 7-11 with a diagnosis of ADHD

  • Parent and child must be fluent English speakers

  • Family has access to desktop/laptop computer at home with internet access (in order to implement the ACTIVATE intervention component, which is an online-based computer program)

Exclusion Criteria:
  • Developmental delay or psychosis that impacts the child's ability to function and engage in the computerized intervention

  • If the youth or parent presents with emergency psychiatric needs that require services beyond that which can be managed within a preventive intervention format (e.g. hospitalization, specialized placement outside the home)

  • If the child has an estimated Full Scale IQ below 80, based on completing two subtests of the Wechsler Intelligence Scale for Children - Fourth Edition

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University New York New York United States 10003

Sponsors and Collaborators

  • New York University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Dr. Anil Chacko, Associate Professor, Department of Applied Psychology, New York University
ClinicalTrials.gov Identifier:
NCT02562469
Other Study ID Numbers:
  • ACTIVATE
First Posted:
Sep 29, 2015
Last Update Posted:
Oct 2, 2018
Last Verified:
Sep 1, 2018

Study Results

No Results Posted as of Oct 2, 2018